Skip to main content
TipRanks
Go Ultimate75% OFF

Bioxcel Therapeutics (BX20) Q2 2018 Earnings Report

10 Followers

DE:BX20 Q2 2018 EPS Results

Actual EPS
-EUR 0.17
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
―

DE:BX20 Q2 2018 Revenue Results

Actual Revenue
EUR 0
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2018
Date
08/08/2018
Time
TBA
Conference Call
Wednesday, August 8, 2018
DE:BX20 Upcoming Earnings

Bioxcel Therapeutics's next earnings date is estimated for March 11, 2027, based on past reporting schedules.

Q2 2018 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2018 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2018 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:BX20 Earnings History

DE:BX20 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 11, 20272026 (Q4)―--0.53――
Nov 18, 20262026 (Q3)-0.92--1.99―
Aug 11, 20262026 (Q2)-0.40-0.44-2.2380.16% (+1.79)
May 15, 20262026 (Q1)-0.48-0.49-1.3764.00% (+0.88)
Mar 27, 20262025 (Q4)-0.58-0.53-3.2583.75% (+2.73)
Nov 12, 20252025 (Q3)-1.22-1.99-4.6757.42% (+2.68)
Aug 12, 20252025 (Q2)-1.69-2.23-3.0627.08% (+0.83)
May 12, 20252025 (Q1)-2.48-1.37-12.6989.22% (+11.32)
Mar 27, 20252024 (Q4)-5.51-3.25-11.0870.64% (+7.83)
Nov 14, 20242024 (Q3)-7.37-4.67-25.0981.40% (+20.42)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed